NRx Defense Systems wins $11.18 million DARPA contract for depression trial

DARPA prime contract worth $11.18 million will fund SPARC-TMS, a trial combining one-day robotic neuronavigated TMS with investigational NRX-101 for treatment-resistant depression, with enrollment starting at McLean Hospital and affiliates.